Sequenom, Inc. v. Ariosa Diagnostics, Inc.
Certiorari Denied
Petition for certiorari denied on June 27, 1916.
Issue
Whether a novel method is patent-eligible where: (1) a researcher is the first to discover a natural phenomenon; (2) that unique knowledge motivates him to apply a new combination of known techniques to that discovery; and (3) he thereby achieves a previously impossible result without preempting other uses of the discovery.
Feb 18, 2016Application (15A871) to extend the time to file a petition for a writ of certiorari from March 1, 2016 to April 1, 2016, submitted to The Chief Justice.
Feb 22, 2016Application (15A871) granted by The Chief Justice extending the time to file until April 1, 2016.
Mar 21, 2016Petition for a writ of certiorari filed. (Response due April 20, 2016)
Mar 28, 2016Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for petitioner.
Mar 28, 2016Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for respondent Ariosa Diagnostics, Inc. ("Ariosa").
Mar 30, 2016Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for respondent DNA Diagnostics Center, Inc.("DDC").
Mar 31, 2016Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for respondent Natera, Inc..
Mar 31, 2016Order extending time to file response to petition to and including May 20, 2016, for all respondents.
Apr 1, 2016Brief amici curiae of Eli Lilly and Company, et al. filed.Apr 15, 2016Brief amicus curiae of The Chartered Institute of Patent Attorneys filed.
Apr 18, 2016Brief amicus curiae of Intellectual Property Owners Association filed.
Apr 19, 2016Brief amicus curiae of Dr. Ananda Mohan Chakrabarty filed.
Apr 19, 2016Brief amici curiae of BioIndustry Association, et al. filed.
Apr 19, 2016Brief amicus curiae of New York Intellectual Property Law Association filed.
Apr 20, 2016Brief amicus curiae of Metabolon, Inc. filed.
Apr 20, 2016Brief amicus curiae of Coalition for 21st Century Medicine filed.
Apr 20, 2016Brief amicus curiae of Novartis AG filed.
Apr 20, 2016Brief amicus curiae of Microsoft Corporation filed.
Apr 20, 2016Brief amici curiae of Professor Jeffrey A. Lefstin, et al. filed.
Apr 20, 2016Brief amicus curiae of Murgitroyd & Company filed.
Apr 20, 2016Brief amici curiae of Biotechnology Innovation Organization, et al. filed.
Apr 20, 2016Brief amici curiae of Amarantus Bioscience Holdings, Inc., et al. filed.
Apr 20, 2016Brief amici curiae of Population Diagnostics, Inc., et al. filed.
Apr 20, 2016Brief amicus curiae of JYANT Technologies, Inc. filed.
Apr 20, 2016Brief amici curiae of 19 Law Professors filed.
Apr 20, 2016Brief amici curiae of Professor Timo Minssen, et al. filed.
Apr 20, 2016Brief amicus curiae of Institute of Professional Representatives before the European Patent Office filed.
Apr 20, 2016Brief amicus curiae of Federal Circuit Bar Association filed.
Apr 20, 2016Brief amici curiae of Wisconsin Alumni Research Foundation, et al. filed.
Apr 20, 2016Brief amicus curiae of Boston Patent Law Association filed.
May 20, 2016Brief of respondents Natera, Inc., et al. in opposition filed.
May 20, 2016Brief of respondent Ariosa Diagnostics, Inc. in opposition filed.
Jun 6, 2016Reply of petitioner Sequenom, Inc. filed.
Jun 7, 2016DISTRIBUTED for Conference of June 23, 2016.
Jun 27, 2016Petition DENIED.
Recommended Citation: Sequenom, Inc. v. Ariosa Diagnostics, Inc., SCOTUSblog, https://www.scotusblog.com/cases/sequenom-inc-v-ariosa-diagnostics-inc/